APO RESEARCH · REPORT
Buprenorphine Hydrochloride
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
Product & engineering
Understand the product.
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
Selected research
Industry Research
Buprenorphine Hydrochloride Industry Research Report 2026
Market perspective
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
Europe is the largest market with about 31% market share. Middle East& Africa and Asia-Pacific are follower.
The main manufacturers are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Micro Orgo Chem, Faranshimi etc. Siegfried is the largest manufacturer with about 23% market share.
Read the full market overview
Report Scope
This report quantifies the global Buprenorphine Hydrochloride market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Buprenorphine Hydrochloride Market by Company
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Buprenorphine Hydrochloride Segment by Type
Tablets
Injection
Buprenorphine Hydrochloride Segment by Application
Analgesic
Opioid Antagonist
Buprenorphine Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buprenorphine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Buprenorphine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buprenorphine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Buprenorphine Hydrochloride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Buprenorphine Hydrochloride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Buprenorphine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Injection
Applications
- Analgesic
- Opioid Antagonist
Companies covered
- Siegfried
- Sanofi
- Johnson Matthey
- Mallinckrodt
- Noramco
- Unichemlabs
- Arevipharma
- Resonance-labs
- Sun Pharma
- Rusan Pharma
- Micro Orgo Chem
- Faranshimi
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Buprenorphine Hydrochloride Market Size (2021-2032)
- 2.2.2 Global Buprenorphine Hydrochloride Sales (2021-2032)
- 2.2.3 Global Buprenorphine Hydrochloride Market Average Price (2021-2032)
- 2.3 Buprenorphine Hydrochloride by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Injection
- 2.4 Buprenorphine Hydrochloride by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Analgesic
- 2.4.3 Opioid Antagonist
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Buprenorphine Hydrochloride Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Buprenorphine Hydrochloride Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Buprenorphine Hydrochloride Revenue of Manufacturers (2021-2026)
- 3.4 Global Buprenorphine Hydrochloride Average Price by Manufacturers (2021-2026)
- 3.5 Global Buprenorphine Hydrochloride Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Buprenorphine Hydrochloride, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Buprenorphine Hydrochloride, Product Type & Application
- 3.8 Global Manufacturers of Buprenorphine Hydrochloride, Established Date
- 3.9 Global Buprenorphine Hydrochloride Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Siegfried
- 4.1.1 Siegfried Company Information
- 4.1.2 Siegfried Business Overview
- 4.1.3 Siegfried Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Siegfried Buprenorphine Hydrochloride Product Portfolio
- 4.1.5 Siegfried Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Buprenorphine Hydrochloride Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Johnson Matthey
- 4.3.1 Johnson Matthey Company Information
- 4.3.2 Johnson Matthey Business Overview
- 4.3.3 Johnson Matthey Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Johnson Matthey Buprenorphine Hydrochloride Product Portfolio
- 4.3.5 Johnson Matthey Recent Developments
- 4.4 Mallinckrodt
- 4.4.1 Mallinckrodt Company Information
- 4.4.2 Mallinckrodt Business Overview
- 4.4.3 Mallinckrodt Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mallinckrodt Buprenorphine Hydrochloride Product Portfolio
- 4.4.5 Mallinckrodt Recent Developments
- 4.5 Noramco
- 4.5.1 Noramco Company Information
- 4.5.2 Noramco Business Overview
- 4.5.3 Noramco Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Noramco Buprenorphine Hydrochloride Product Portfolio
- 4.5.5 Noramco Recent Developments
- 4.6 Unichemlabs
- 4.6.1 Unichemlabs Company Information
- 4.6.2 Unichemlabs Business Overview
- 4.6.3 Unichemlabs Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Unichemlabs Buprenorphine Hydrochloride Product Portfolio
- 4.6.5 Unichemlabs Recent Developments
- 4.7 Arevipharma
- 4.7.1 Arevipharma Company Information
- 4.7.2 Arevipharma Business Overview
- 4.7.3 Arevipharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Arevipharma Buprenorphine Hydrochloride Product Portfolio
- 4.7.5 Arevipharma Recent Developments
- 4.8 Resonance-labs
- 4.8.1 Resonance-labs Company Information
- 4.8.2 Resonance-labs Business Overview
- 4.8.3 Resonance-labs Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Resonance-labs Buprenorphine Hydrochloride Product Portfolio
- 4.8.5 Resonance-labs Recent Developments
- 4.9 Sun Pharma
- 4.9.1 Sun Pharma Company Information
- 4.9.2 Sun Pharma Business Overview
- 4.9.3 Sun Pharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sun Pharma Buprenorphine Hydrochloride Product Portfolio
- 4.9.5 Sun Pharma Recent Developments
- 4.10 Rusan Pharma
- 4.10.1 Rusan Pharma Company Information
- 4.10.2 Rusan Pharma Business Overview
- 4.10.3 Rusan Pharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Rusan Pharma Buprenorphine Hydrochloride Product Portfolio
- 4.10.5 Rusan Pharma Recent Developments
- 4.11 Micro Orgo Chem
- 4.11.1 Micro Orgo Chem Company Information
- 4.11.2 Micro Orgo Chem Business Overview
- 4.11.3 Micro Orgo Chem Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Micro Orgo Chem Buprenorphine Hydrochloride Product Portfolio
- 4.11.5 Micro Orgo Chem Recent Developments
- 4.12 Faranshimi
- 4.12.1 Faranshimi Company Information
- 4.12.2 Faranshimi Business Overview
- 4.12.3 Faranshimi Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Faranshimi Buprenorphine Hydrochloride Product Portfolio
- 4.12.5 Faranshimi Recent Developments
5 Global Buprenorphine Hydrochloride Market Scenario by Region
- 5.1 Global Buprenorphine Hydrochloride Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Buprenorphine Hydrochloride Sales by Region: 2021-2032
- 5.2.1 Global Buprenorphine Hydrochloride Sales by Region: 2021-2026
- 5.2.2 Global Buprenorphine Hydrochloride Sales by Region: 2027-2032
- 5.3 Global Buprenorphine Hydrochloride Revenue by Region: 2021-2032
- 5.3.1 Global Buprenorphine Hydrochloride Revenue by Region: 2021-2026
- 5.3.2 Global Buprenorphine Hydrochloride Revenue by Region: 2027-2032
- 5.4 North America Buprenorphine Hydrochloride Market Facts & Figures by Country
- 5.4.1 North America Buprenorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Buprenorphine Hydrochloride Sales by Country (2021-2032)
- 5.4.3 North America Buprenorphine Hydrochloride Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Buprenorphine Hydrochloride Market Facts & Figures by Country
- 5.5.1 Europe Buprenorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Buprenorphine Hydrochloride Sales by Country (2021-2032)
- 5.5.3 Europe Buprenorphine Hydrochloride Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Buprenorphine Hydrochloride Market Facts & Figures by Country
- 5.6.1 Asia Pacific Buprenorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Buprenorphine Hydrochloride Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Buprenorphine Hydrochloride Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Buprenorphine Hydrochloride Market Facts & Figures by Country
- 5.7.1 South America Buprenorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Buprenorphine Hydrochloride Sales by Country (2021-2032)
- 5.7.3 South America Buprenorphine Hydrochloride Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Buprenorphine Hydrochloride Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Buprenorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Buprenorphine Hydrochloride Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Buprenorphine Hydrochloride Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Buprenorphine Hydrochloride Sales by Type (2021-2032)
- 6.1.1 Global Buprenorphine Hydrochloride Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Buprenorphine Hydrochloride Sales Market Share by Type (2021-2032)
- 6.2 Global Buprenorphine Hydrochloride Revenue by Type (2021-2032)
- 6.2.1 Global Buprenorphine Hydrochloride Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Buprenorphine Hydrochloride Revenue Market Share by Type (2021-2032)
- 6.3 Global Buprenorphine Hydrochloride Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Buprenorphine Hydrochloride Sales by Application (2021-2032)
- 7.1.1 Global Buprenorphine Hydrochloride Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Buprenorphine Hydrochloride Sales Market Share by Application (2021-2032)
- 7.2 Global Buprenorphine Hydrochloride Revenue by Application (2021-2032)
- 7.2.1 Global Buprenorphine Hydrochloride Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Buprenorphine Hydrochloride Revenue Market Share by Application (2021-2032)
- 7.3 Global Buprenorphine Hydrochloride Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Buprenorphine Hydrochloride Value Chain Analysis
- 8.1.1 Buprenorphine Hydrochloride Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Buprenorphine Hydrochloride Production Mode & Process
- 8.2 Buprenorphine Hydrochloride Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Buprenorphine Hydrochloride Distributors
- 8.2.3 Buprenorphine Hydrochloride Customers
9 Global Buprenorphine Hydrochloride Analyzing Market Dynamics
- 9.1 Buprenorphine Hydrochloride Industry Trends
- 9.2 Buprenorphine Hydrochloride Industry Drivers
- 9.3 Buprenorphine Hydrochloride Industry Opportunities and Challenges
- 9.4 Buprenorphine Hydrochloride Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst